SANOFI (SNW.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SNW - FR0000120578 - Common Stock
85.76 EUR
+0.18 (+0.21%)
SNW gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. While SNW belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. SNW is not valued too expensively and it also shows a decent growth rate. SNW also has an excellent dividend rating. These ratings could make SNW a good candidate for dividend investing.
1. Profitability
1.1 Basic Checks
In the past year SNW was profitable.
In the past year SNW had a positive cash flow from operations.
In the past 5 years SNW has always been profitable.
Each year in the past 5 years SNW had a positive operating cash flow.
1.2 Ratios
SNW has a better Return On Assets (11.05%) than 76.36% of its industry peers.
SNW has a Return On Equity of 19.73%. This is in the better half of the industry: SNW outperforms 63.64% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.84%, SNW is in the better half of the industry, outperforming 67.27% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SNW is significantly below the industry average of 14.90%.
The 3 year average ROIC (7.31%) for SNW is below the current ROIC(13.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
SNW has a Profit Margin of 20.35%. This is in the better half of the industry: SNW outperforms 78.18% of its industry peers.
In the last couple of years the Profit Margin of SNW has grown nicely.
With a Operating Margin value of 23.59%, SNW perfoms like the industry average, outperforming 56.36% of the companies in the same industry.
SNW's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 71.70%, SNW perfoms like the industry average, outperforming 49.09% of the companies in the same industry.
SNW's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SNW is creating value.
SNW has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, SNW has about the same amount of shares outstanding.
Compared to 1 year ago, SNW has an improved debt to assets ratio.
2.2 Solvency
SNW has a debt to FCF ratio of 2.21. This is a good value and a sign of high solvency as SNW would need 2.21 years to pay back of all of its debts.
SNW has a Debt to FCF ratio of 2.21. This is amongst the best in the industry. SNW outperforms 85.45% of its industry peers.
SNW has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
SNW's Debt to Equity ratio of 0.21 is fine compared to the rest of the industry. SNW outperforms 76.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.81
WACC7.65%
2.3 Liquidity
A Current Ratio of 1.27 indicates that SNW should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.27, SNW is doing worse than 61.82% of the companies in the same industry.
SNW has a Quick Ratio of 1.27. This is a bad value and indicates that SNW is not financially healthy enough and could expect problems in meeting its short term obligations.
SNW has a Quick ratio (0.94) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for SNW have decreased by -5.35% in the last year.
Measured over the past 5 years, SNW shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
The Revenue has been growing slightly by 2.56% in the past year.
SNW shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.31% yearly.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
The Earnings Per Share is expected to grow by 7.11% on average over the next years.
The Revenue is expected to grow by 4.55% on average over the next years.
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.11%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
SNW is valuated reasonably with a Price/Earnings ratio of 11.28.
Based on the Price/Earnings ratio, SNW is valued cheaper than 83.64% of the companies in the same industry.
When comparing the Price/Earnings ratio of SNW to the average of the S&P500 Index (26.31), we can say SNW is valued rather cheaply.
A Price/Forward Earnings ratio of 9.99 indicates a reasonable valuation of SNW.
80.00% of the companies in the same industry are more expensive than SNW, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of SNW to the average of the S&P500 Index (36.59), we can say SNW is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.28 | ||
| Fwd PE | 9.99 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SNW indicates a somewhat cheap valuation: SNW is cheaper than 61.82% of the companies listed in the same industry.
SNW's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.68 | ||
| EV/EBITDA | 10.98 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SNW does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SNW may justify a higher PE ratio.
PEG (NY)3.68
PEG (5Y)2.21
EPS Next 2Y5.75%
EPS Next 3Y6.01%
5. Dividend
5.1 Amount
SNW has a Yearly Dividend Yield of 4.56%, which is a nice return.
Compared to an average industry Dividend Yield of 2.86, SNW pays a better dividend. On top of this SNW pays more dividend than 85.45% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, SNW pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.56% |
5.2 History
The dividend of SNW has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
34.82% of the earnings are spent on dividend by SNW. This is a low number and sustainable payout ratio.
SNW's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.82%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
FRA:SNW (11/28/2025, 7:00:00 PM)
85.76
+0.18 (+0.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners47.5%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap208.31B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target108.63 (26.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.56% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-0.86%
PT rev (3m)-0.99%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)-1.01%
EPS NY rev (3m)-0.81%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-1.69%
Revenue NY rev (1m)0.96%
Revenue NY rev (3m)0.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.28 | ||
| Fwd PE | 9.99 | ||
| P/S | 3.07 | ||
| P/FCF | 20.68 | ||
| P/OCF | 18.3 | ||
| P/B | 2.98 | ||
| P/tB | 22.41 | ||
| EV/EBITDA | 10.98 |
EPS(TTM)7.6
EY8.86%
EPS(NY)8.59
Fwd EY10.01%
FCF(TTM)4.15
FCFY4.83%
OCF(TTM)4.69
OCFY5.46%
SpS27.95
BVpS28.82
TBVpS3.83
PEG (NY)3.68
PEG (5Y)2.21
Graham Number70.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.65%
ROIC/WACC1.81
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.11%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.55%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year30.73%
EBIT Next 3Y13.89%
EBIT Next 5Y11.66%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI / SNW.DE FAQ
Can you provide the ChartMill fundamental rating for SANOFI?
ChartMill assigns a fundamental rating of 6 / 10 to SNW.DE.
Can you provide the valuation status for SANOFI?
ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SNW.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SANOFI?
SANOFI (SNW.DE) has a profitability rating of 7 / 10.
What is the financial health of SANOFI (SNW.DE) stock?
The financial health rating of SANOFI (SNW.DE) is 5 / 10.
What is the expected EPS growth for SANOFI (SNW.DE) stock?
The Earnings per Share (EPS) of SANOFI (SNW.DE) is expected to grow by 3.07% in the next year.